enormous level and simply does not happen in real-world testing situations. Heroin breaks down from the above compound quickly (in as litle as 45 minutes to a few hours aſter ingestion), and will be easily picked up as codeine(minor) and morphine, as the levels are typically very high.
12 Panel Test Cards* Te tests available on a 12 panel test card for the opiate family are the standard opiate test at 2000ng/mL, oxycodone test at 100 ng/mL, and propoxyphene test at 300 ng/mL. Comparing the detection levels of substances also checked by the 5 panel card, drastic differences are seen. • Hydrocodone—1,562 ng/mL (under the OXY test)
• Hydromorphone—5,000 ng/mL (under the OPI test)
• Oxycodone—100 ng/mL (under the OXY test)
• Oxymorphone—1,562 ng/mL (under the OXY test)
• Propoxyphene—300 ng/mL (under the PPX test)
• Heroin—5,000ng/mL As these numbers show, the 12 panel test
card is far superior in detecting synthetic and semi-synthetic opioids. In 2013, prescription painkillers overtook cocaine as the #2 most abused drug class (marijuana is #1, as always). Te most abused painkillers are the hydrocodone and oxycodone families. A 12 panel drug test does a much beter job of detecting these substances at lower concentration levels. *Information obtained fom Innovacon white labelled product insert
Drug Testing
Recommendations For any company that is concerned about painkiller drug abuse, it is highly recommended that they adopt a 12 panel POCT drug test to detect semi-synthetic and synthetic opioids rather than the 5 panel test. It is also recommended that
www.datia.org
their drug and alcohol policy be amended to reflect the cut-off concentrations for the additional tests. Company drug and substance use/abuse policies should also include wording to require all employees let their supervisor or safety personnel know about any prescription painkillers that may have safety sensitive warnings with their use. As with any screening drug test, all positive results must be confirmed by a secondary lab test such as GC/MS or LC-MS/MS. ❚
John Hawes is the CCO and co-founder at SureHire Occupational Health Testing and the president and co-founder of
WorkplaceTesting.com. John
graduated in 2001 from the University of Alberta with a Bachelor of Science degree in physical therapy. From 2001 until 2013 John was a treating therapist and co-owned three physical therapy clinics. In 2005, John and his business partner started SureHire, an occupational health testing company based in Edmonton, Alberta.
John has used his knowledge of physical therapy and interest in ergonomic and biomechanics to devise fit-for-work testing unlike anything seen in Canada before. SureHire grew quickly and expanded its services to become one of the largest occupational health testing companies in Canada.
John’s primary role in the company now is on research and best practices for every type of testing that SureHire offers. John’s belief is that occupational health testing is an ever-growing and evolving field and requires continual refinement regarding policies, procedures and embracing new technologies to get the best possible employees. This helps improve the overall health of the workforce and also provides companies with the best possible picture of their workforce, both as a whole and of each individual worker.
datia focus 31
For any company that is concerned about painkiller drug abuse, it is highly recommended that they adopt a 12 panel POCT drug test to detect semi-synthetic and synthetic opioids rather than the 5 panel test.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
